NASDAQ:CERN - Nasdaq - US1567821046 - Common Stock
94.92
-0.05 (-0.05%)
The current stock price of CERN is 94.92 null. In the past month the price increased by 1.33%. In the past year, price increased by 16.8%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
Cerner Corp. designs, develops, markets, installs, hosts and supports health care information technology, health care devices, hardware and content solutions for health care organizations and consumers. The company is headquartered in North Kansas City, Missouri and currently employs 25,150 full-time employees. The firm offers intelligent solutions and technology-enabled services that support the clinical, financial and operational needs of organizations. The firm's segments include Domestic segment includes revenue contributions and expenditures associated with business activity in the United States, and the International segment includes revenue contributions and expenditures linked to business activity outside the United States, primarily from Australia, Canada, Europe, and the Middle East. The company also offers integrated clinical and financial systems to help manage day-to-day revenue functions to support clinical, financial and operational needs. Cerner's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Cerner also has an electronic health record (EHR) agnostic platform, CareAware, which facilitates connectivity of healthcare devices to EHRs.
CERNER CORP
2800 Rockcreek Pkwy, W0162, Attn: Cerner Legal
North Kansas City MISSOURI 64117 US
CEO: Brent Shafer
Employees: 25150
Company Website: https://www.cerner.com/
Phone: 18162211024.0
The current stock price of CERN is 94.92 null. The price decreased by -0.05% in the last trading session.
The exchange symbol of CERNER CORP is CERN and it is listed on the Nasdaq exchange.
CERN stock is listed on the Nasdaq exchange.
21 analysts have analysed CERN and the average price target is 96.34 null. This implies a price increase of 1.5% is expected in the next year compared to the current price of 94.92. Check the CERNER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CERNER CORP (CERN) has a market capitalization of 27.92B null. This makes CERN a Large Cap stock.
CERNER CORP (CERN) currently has 25150 employees.
CERNER CORP (CERN) has a support level at 94.76 and a resistance level at 94.97. Check the full technical report for a detailed analysis of CERN support and resistance levels.
The Revenue of CERNER CORP (CERN) is expected to grow by 3.95% in the next year. Check the estimates tab for more information on the CERN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CERNER CORP (CERN) has a dividend yield of 1.14%. The yearly dividend amount is currently 0.93. Check the full fundamental report for a detailed analysis of CERN dividend history, reliability and sustainability.
CERNER CORP (CERN) will report earnings on 2022-07-28.
The PE ratio for CERNER CORP (CERN) is 27.28. This is based on the reported non-GAAP earnings per share of 3.48 and the current share price of 94.92 null. Check the full fundamental report for a full analysis of the valuation metrics for CERN.
ChartMill assigns a technical rating of 7 / 10 to CERN. When comparing the yearly performance of all stocks, CERN is one of the better performing stocks in the market, outperforming 93.89% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CERN. While CERN has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months CERN reported a non-GAAP Earnings per Share(EPS) of 3.48. The EPS increased by 20.42% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.15% | ||
ROA | 7.99% | ||
ROE | 15.08% | ||
Debt/Equity | 0.41 |
ChartMill assigns a Buy % Consensus number of 71% to CERN. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 12.81% and a revenue growth 3.95% for CERN